unapproved

FDA Advisory Panel Recommends Allowing Compounding Pharmacies to Manufacture Key Peptides, Signaling Potential Shift in Access to Unapproved Compounds

WASHINGTON – An advisory panel to the Food and Drug Administration (FDA) has recommended that compounding pharmacies be permitted to…